Arvinas focuses on protein degradation, with its lead candidate, ARV-471, in Phase 3 trials for breast cancer. Read why we ...

The companies argue that combining their firepower makes sense as they fight back against the likes of Tesla as well as ...

Among smaller companies, Windward surged 41%. The Tel Aviv-based maritime predictive intelligence company has agreed to a recommended acquisition offer by FTV VIII LP which values its share capital at ...

Christmas is just one day away. Every year in December, there is high anticipation for a 'Santa rally' in the stock market, ...

Cytokinetics finds a new partner in Greater China for its potential blockbuster drug — it could be one of a handful of ...

Rupee hits all-time low against USD due to strong dollar, weak Chinese yuan, importer demand, and Fed rate cut concerns.

A survey by Lloyds Bank found that optimism has been eroded to end 2024 at the lowest level recorded all year.

Stock market bulls fought back Friday, mitigating a bearish week. Palantir was among the winners. A government shutdown ...

The central bank’s interventions in the inter-bank forex market coupled to a softer Dollar Index (DXY which gauges the dollar ...

Stocks signaled another rough day of trading on Friday after the House of Representatives voted against a Trump-backed spending bill.

Novo Nordisk's stock is spiraling downwards, with technical analysis revealing a concerning picture of bearish momentum.

Friday announced the pricing of a follow-on public offering, comprising of about 12.4 million common units and ...